Market closed

Alvotech/$ALVO

14:30
16:10
17:45
19:25
21:00
1D1W1MYTD1Y5YMAX

About Alvotech

Alvotech is an integrated biopharmaceutical company committed to developing and manufacturing high-quality biosimilar medicines for patients globally. its purpose is to improve the health and quality of life of patients around the world by improving access to proven treatments for various diseases.

Ticker

$ALVO
Trading on

Industry

Biotechnology

Headquarters

Luxembourg, Luxembourg

Employees

999

Alvotech Metrics

BasicAdvanced
$3.6B
Market cap
-
P/E ratio
-$1.74
EPS
-0.10
Beta
-
Dividend rate
$3.6B
-0.1
$18.00
$9.15
115K
2.695
1.644
-333.628
-343.462
-0.07%
-1.04%
87.89%
7.649
-9.73
-8.88
-10.004
517.92%
-34.54%
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.

Buy $ALVO

$

Sign up or log in to buy
Capital at risk
Market closed

Upcoming events

No upcoming events

FAQs

What’s the current market cap for Alvotech stock?

Alvotech (ALVO) has a market cap of $3.6B as of December 23, 2024.

What is the P/E ratio for Alvotech stock?

The price to earnings (P/E) ratio for Alvotech (ALVO) stock is 0 as of December 23, 2024.

Does Alvotech stock pay dividends?

No, Alvotech (ALVO) stock does not pay dividends to its shareholders as of December 23, 2024.

When is the next Alvotech dividend payment date?

Alvotech (ALVO) stock does not pay dividends to its shareholders.

What is the beta indicator for Alvotech?

Alvotech (ALVO) has a beta rating of -0.1. This means that it has an inverse relation to market volatility.